Stock research

Alexandria Real Estate Equities, Inc. (ARE) Stock Research

Alexandria Real Estate owns life-science laboratory and office campuses leased to biotech and pharma tenants.

Alexandria Real Estate Equities, Inc. reported net income of −$1.4B for the fiscal year ended December 31, 2025. Source: Form 10-K filed January 26, 2026

SEC data as of

Ticker
ARE
Exchange
NYSE
Sector
Real
Founded
—
Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

About Alexandria Real Estate Equities

Exchange
NYSE: ARE
Sector
Real Estate
SEC industry
Real Estate Investment Trusts (SIC 6798)
Fiscal year end
December 31

ARE key financials

Reported figures from Alexandria Real Estate Equities, Inc.'s filings, pulled directly from SEC XBRL data rather than a third-party terminal. Each row links to the filing it came from.

MetricValuePeriodSource
Net income−$1.4B2025-01-01 – 2025-12-31SEC filing
Operating cash flow$1.4B2025-01-01 – 2025-12-31SEC filing
Diluted EPS−$8.442025-01-01 – 2025-12-31SEC filing
Shares outstanding173MAs of 2026-01-15SEC filing

Values are as tagged by the issuer in XBRL. Revenue for banks and insurers is net of interest expense where that is the reported line. Fiscal years that do not follow the calendar are shown by their period-end date. No price, market cap, or valuation multiple is shown because Yield Theory does not republish unlicensed market data.

Diluted EPS is the earnings figure behind the price-to-earnings ratio; the P/E multiple compression calculator shows how a change in that multiple moves a share price. Shares outstanding multiplied by the share price gives market capitalization.

What investors should watch in ARE

Alexandria Real Estate Equities, Inc. sits in Real Estate. REITs across offices, data centers, industrial, and residential — the most rate-sensitive corner of the equity market. We have not yet written company-specific drivers for ARE; the forces that matter most for the sector are:

  • ◆Long-term interest rates and cap rates
  • ◆Occupancy and rent growth by property type
  • ◆Data-center demand from AI workloads
  • ◆Refinancing walls and commercial credit

Congressional trading in ARE

PoliticianTrade dateTypeOwnerAmountSource
Gilbert Cisneros2026-04-14PurchaseSelf$1,001 - $15,000Filing #20034500
Gilbert Cisneros2025-12-19SaleSelf$1,001 - $15,000Filing #20033762
Gilbert Cisneros2025-11-18PurchaseSelf$1,001 - $15,000Filing #20033619
Robert Bresnahan2025-05-15SaleSelf$1,001 - $15,000Filing #20030482
Robert Bresnahan2025-02-25PurchaseSelf$1,001 - $15,000Filing #20029034
Ritchie Torres2024-09-26PurchaseSelf$1,001 - $15,000Filing #20030930

All verified ARE congressional disclosures

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

ARE — frequently asked questions

What does Alexandria Real Estate Equities, Inc. do?

Alexandria Real Estate owns life-science laboratory and office campuses leased to biotech and pharma tenants.

What were ARE's latest reported annual revenue and net income?

Alexandria Real Estate Equities, Inc. reported net income of −$1.4B for the fiscal year ended December 31, 2025. The figures come from Alexandria Real Estate Equities, Inc.'s SEC XBRL filings.

When does Alexandria Real Estate Equities, Inc.'s fiscal year end?

The SEC lists Alexandria Real Estate Equities, Inc.'s fiscal year end as December 31.

Do members of Congress trade ARE?

The current verified House and Senate snapshot contains 6 transaction rows for ARE, each linked to the original filing.

Is ARE a good investment?

This page does not rate ARE as a buy or sell. It sets out what Alexandria Real Estate Equities, Inc. reports, what investors should watch and the questions a thesis has to answer, with links to the SEC filings. It is research, not investment advice.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

What do the ARE numbers leave unanswered?

Financials describe the business. The next question is which assumptions an investment thesis depends on. Explore the member reports below for analysis of catalysts, risks, and what would change the view. $39/month or $249/year.

$39/mo or $249/yr · cancel future renewals anytime · sources included